BeStock  
Stocks › Biotechnology › MNPR

Monopar Therapeutics MNPR

US equityMarket cap rank #3666Biotechnology
$83.78 +$4.21 (+5.29%)
Market closed · Oct 8, 6:30 am ET · Last extended-hours $83.80 +0.02%
Open$78.28
Prev close$79.57
Day range$77.98 – $85.03
Volume107.1K
Market cap$562.35M
P/E (TTM)–
Dividend yield–

Analyst view

ConsensusBuy
Analysts7
Average target$129.29+54.3% vs. price
  • Buy 86%
  • Hold 14%
Low $119.00Now $83.78Avg $129.29High $145.00

Recent rating changes

The last 20 actions on file set price targets from $101.00 to $145.00, averaging $121.90.

DateFirmRatingTarget
28 Sep 2026 Piper Sandler BUY $123.00
21 Sep 2026 H.C. Wainwright BUY $125.00
11 Sep 2026 Barclays BUY $145.00
17 Aug 2026 Morgan Stanley BUY $130.00
13 Aug 2026 H.C. Wainwright BUY $125.00
13 Aug 2026 Barclays BUY $128.00
12 Aug 2026 Cantor Fitzgerald HOLD $119.00
12 Aug 2026 JonesTrading BUY $130.00
12 Aug 2026 BTIG BUY $133.00
23 Jul 2026 Barclays BUY $125.00
22 Jul 2026 BTIG BUY $117.00
22 Jul 2026 Morgan Stanley BUY $115.00
22 Jul 2026 H.C. Wainwright BUY $125.00
1 Jul 2026 BTIG BUY $117.00
30 Jun 2026 BTIG BUY $117.00
30 Jun 2026 Lake Street BUY $103.00
29 Jun 2026 JonesTrading BUY $130.00
29 Jun 2026 Piper Sandler BUY $101.00
29 Jun 2026 H.C. Wainwright BUY $105.00
29 Jun 2026 Barclays BUY $125.00

Discussion

No comments yet — be the first to weigh in on MNPR.

Leave a comment

Scroll to Top